Anahi Yanez

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Journal: BMJ open respiratory research

Published: February 23, 2026

Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.

Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.

Journal: Journal of asthma and allergy

Published: February 10, 2026

What is new on the horizon for the biologics world: New kids of the block - WAO state of art.

What is new on the horizon for the biologics world: New kids of the block - WAO state of art.

Journal: The World Allergy Organization journal

Published: September 02, 2025

Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to action.

Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to action.

Journal: The World Allergy Organization journal

Published: August 24, 2025

Regional challenges to optimize the management of patients with severe asthma type 2 inflammation: a Delphi consensus in seven countries.

Regional challenges to optimize the management of patients with severe asthma type 2 inflammation: a Delphi consensus in seven countries.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: January 24, 2025

Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data.

Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 25, 2024

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).

Journal: The World Allergy Organization journal

Published: December 18, 2024

WAO - ARIA consensus on chronic cough: Executive summary.

WAO - ARIA consensus on chronic cough: Executive summary.

Journal: The World Allergy Organization journal

Published: August 29, 2024

Allergic and hypersensitivity condition in the International Patients' Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11.

Allergic and hypersensitivity condition in the International Patients' Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11.

Journal: The World Allergy Organization journal

Published: January 23, 2024

Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study.

Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: September 06, 2022

Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group.

Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group.

Journal: The World Allergy Organization journal

Published: August 01, 2022

WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19.

WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19.

Journal: The World Allergy Organization journal

Published: January 11, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026